Wai Yuen Tong Medicine Holdings Limited (HKG:897) Held Back By Insufficient Growth Even After Shares Climb 47%

Simply Wall StJun 28 18:07 ET

Wai Yuen Tong Medicine's Losses Shrink in Fiscal Year 2024; Shares Surge 34%

MT NewswiresJun 27 03:23 ET

Stock Market News: Wai Yuen Tong (00897) surged more than 52%, annual losses narrowed by 25%, and a final dividend and special dividend of 17.7 Hong Kong cents were declared.

Wai Yuen Tong (00897) surged more than 52% according to the Zhītōngcáijīng APP. As of publication, it increased by 52.26%, with volume of 2.1572 million Hong Kong dollars. In terms of news, Wai Yuen Tong released its annual results for the year ending March 31, 2024. The group achieved a revenue of 780 million Hong Kong dollars, an increase of 8.3% year-on-year, while the parent company's loss decreased by 25.15% to 15.356 million Hong Kong dollars. A final dividend of HK$0.03 per share and a special dividend of HK$0.147 per share are planned to be distributed. The company indicates that the reduced loss is mainly due to an increase in gross profit generated from the production and sale of pharmaceutical and health food products.

Zhitong FinanceJun 26 21:41 ET

Wai Yuen Tong (00897) will distribute a final dividend of HKD 0.03 per share on September 6th.

Wei Yuen Tong (00897) announced that the company will distribute a final dividend of 0.03 per share on September 6, 2024.

Zhitong FinanceJun 26 19:55 ET

Wai Yuen Tong (00897) released its annual performance, with shareholders' net loss of HKD 15.356 million, a 25.15% decrease year-on-year.

Wai Yuen Tong (00897) announced its annual performance as of March 31, 2024, with a revenue of 7.84 billion...

Zhitong FinanceJun 26 10:59 ET

Express News | Wai Yuen Tong Medicine Holdings FY Gross Profit HKD 394.8 Million

ReutersJun 26 10:55 ET